{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-105591","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2023-04-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.066632+00:00","generated_at":"2026-06-16T23:22:01.807139+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Elevance Health Q1 EPS $8.30 GAAP, $9.46 adjusted; raises full-year guidance","bullets":["GAAP net income $8.30/share; adjusted net income $9.46/share, beating expectations.","Operating revenue $41.9B, up 10.6% YoY; operating gain $2.8B, up 16.6% YoY.","Medical enrollment 48.1M, up 1.3M YoY driven by Medicaid, Medicare Advantage, ACA.","Raised 2023 outlook: GAAP EPS >$29.50, adjusted EPS >$32.70.","Q2 dividend $1.48/share declared; payable June 23 to holders of record June 9."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-105591","json":"https://secwatch.observer/filing/0001193125-23-105591.json","markdown":"https://secwatch.observer/filing/0001193125-23-105591.md","text":"https://secwatch.observer/filing/0001193125-23-105591.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523105591/0001193125-23-105591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523105591/d490195d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T23:22:01.807139+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b7535e2e3ef0a2c3db38610b73f695d1c4204dfc","claim":"Elevance Health, Inc. reported the quarter ended March 31, 2023 results: revenue $41.9 billion, net income $8.30 per share, EPS $8.30 per share. Guidance raised.","evidence_excerpt":"was $8.30 per share, including net negative adjustment items of $1.16 per share. Adjusted net income was $9.46* per share. • Operating revenue grew 10.6% year-over-year to $41.9 billion • Operating gain grew 16.6% year-over-year to $2.8 billion • Medical enrollment increased 1.3 million members year-over-year to 48.1 million members • Second quarter 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523105591/0001193125-23-105591-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2023"},{"label":"Revenue","value":"$41.9 billion"},{"label":"Net income","value":"$8.30 per share"},{"label":"EPS","value":"$8.30 per share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}